Midgestation embryos were infected with replication-defective retroviral vectors that either transduced the myc oncogene, the ras oncogene, or both oncogenes simultaneously. The myc virus induced tumors in diverse organs at a very low frequency and with a long latency period, while -20% of the mice derived from embryos infected with the ras virus developed tumors in the skin with a latency of 4-8 weeks.
tissues after a median latency period of 2-3 weeks. All tumors were ofmonoclonal origin, as shown by Southern analysis using the provirus as a molecular marker. Our results are consistent with the hypothesis that the ras and myc oncogenes cooperate in transforming cells, but that additional alterations are necessary for realization of the fully malignant phenotype. Our observations also suggest that a much wider range of cell types become targets for malignant transformation when the embryos are exposed to the myc and the ras oncogenes simultaneously than when exposed to the same oncogenes separately. Infection of mouse embryos with vectors carrying different oncogenes or oncogene combinations may be an efficient and rapid method for evaluating the spectrum of cell types at risk for malignant conversion following mutation of a protooncogene to a transforming gene.
Development of cancer is a multistep process involving multiple alterations of the cellular genome (1) (2) (3) and current models suggest that mutations occur in protooncogenes, resulting in the generation ofoncogenes. Although oncogenes are expressed in numerous tumor types, the activity of the proteins encoded by these genes is still unclear. Land et al. (4, 5) and Ruley (6) established a system to distinguish between the functions of several oncogenes. While the myc oncogene allowed primary cells to be permanently established in culture, introduction of the ras family of oncogenes elicited a transformed phenotype in cells without prolonging their life-span. Primary fibroblasts containing only one oncogene were not tumorigenic upon injection into nude mice but became tumorigenic when expressing both types of oncogenes. More recently, Sinn et al. (7) generated two strains of mice carrying the myc and ras genes, respectively, with each oncogene transcribed from the mouse mammary tumor virus promoter. When interbred, tumor formation was much more rapid in the F1 generation than in the parent strains carrying a single oncogene. Tumor development was, however, still stochastic and clonal. This observation led to the important conclusion that although myc and ras proteins cooperated in vivo, additional alterations were needed to induce tumor formation.
In this study, we have introduced the ras and/or myc oncogene into midgestation mouse embryos. The genes were under the transcriptional control of the viral long terminal repeat, which is active in most or all cell types of the midgestation mouse embryo (8) (9) (10) . This experimental approach allowed us to evaluate the types of cells that are susceptible to malignant transformation when exposed to the ras or myc oncogenes individually or when exposed to both oncogenes simultaneously.
MATERIALS AND METHODS
Derivation of Viral Vectors. The construction and characterization of the replication-defective retroviruses used in these experiments are detailed elsewhere (11, 12) and are illustrated in Fig. 1 . All of the vectors are based on the transcriptional regulatory sequences of Moloney murine leukemia virus (13) . The v-myc oncogene was derived from the MC29 chicken leukemia virus (14) .
Titration of Virus Supernatants. Virus supernatants were concentrated and titered as described (12) . Those viruses that did not carry a neomycin-resistance marker were titered by focus-forming assays (colony-forming units) or by extracting RNA from the concentrated virus stocks followed by dot blot analysis. Viruses containing a neo marker were used to standardize the assay (15) .
Injection of Mouse Embryos in Utero. Females of three inbred strains (C57BL/6J, BALB/c, and FVB/N) were mated with males ofthe same strain and the day of the vaginal plug was counted as day 0 of gestation. Embryos were infected by microinjection of either qi-2 cells producing virus or concentrated viral stocks directly through the uterine wall as described (8) . The virus producer cells were pretreated with mitomycin C at 20 ,tg/ml for 2 hr to prevent cell division while permitting virus production.
Histology and Immunohistochemistry. Lesions were fixed in 10% buffered formalin and then dehydrated in graded alcohols and xylenes (16) . The tissues were embedded in paraplast and 4-tum sections were prepared and stained with Harris' hematoxylin and eosin (16) . Immunohistochemistry was performed as described (12) . Rabbit antibodies to bovine muzzle keratins (1:80 dilution; Dako Corporation, Santa Barbara, California), myoglobin (1:500; Dako), S100 to be lethal to the developing embryo because only 1% of the fetuses survived beyond birth when 5000 colony-forming units (cfu) were injected. Live animals, however, were obtained when the virus inoculum was diluted to 1000 cfu or when producer cells were used for the injection. Table 1 shows that tumors developed in 27% ofthe surviving animals. The tumors developed rapidly with 20%6 appearing by 1.5 weeks of age and 77% prior to 4 weeks of age with a median latency of 3 weeks (Fig. 2) .
A total of 39 tumors, which arose in different organs and were associated with a variety of phenotypes, were detected in 138 mice derived from injected embryos. Thirty-two percent of the animals with lesions appeared to have a loss of normal motor function exhibiting a circular motion or partial limb paralysis. Upon autopsy, most of these animals were found to have brain lesions. In addition, 15 tumors involved the skin. Five tumors occurred in the peritoneal or pleural cavity and involved liver, kidney, lung, or the rib cage.
To examine whether the rapid tumor induction after injection of the ras/myc virus required simultaneous expression of both the ras and the myc oncogene in the embryonic cells, embryos were injected with retroviral constructs that transduced either the ras or the myc virus ( Fig. 1 ). Previous studies (12) had shown that injection of a vector transducing the human c-HRASJ oncogene was not lethal but led to skin lesions in 20% of the animals after a latency period of4 weeks (Table 1) . After injection of embryos with a retroviral construct transducing the myc oncogene, only 5 of 286 animals developed tumors and these occurred in the eye, ovary, liver, lung, or gastrointestinal tract after a latency period of 15-22 weeks (Table 1) .
Our results allow the following conclusions. While transduction of the myc oncogene alone into midgestation embryos induced tumors very inefficiently, the ras oncogene caused skin lesions but not other tumors with a high efficiency (12) . In contrast, tumor formation in a great variety of tissues was induced when both oncogenes were jointly transduced into the developing embryo. The rasimyc virus was much more effective in causing tumors than the ras virus, which induced mainly skin tumors with a latency of 4 weeks after injection of 5000 cfu into embryos. When the same dose of the ras/myc virus was used, few of the injected embryos Histologic Analysis. All tumors were examined by light microscopy. Five lesions arose in mice infected with the myc virus. Two of these were benign. One was a benign hamartoma in a lung and the other was an inflammatory lesion in the gastrointestinal tract. The three malignant lesions were an ovarian stromal tumor, a poorly differentiated carcinoma of unknown origin, and malignant spindle cell tumor replacing an eye. Previous microscopic analyses of lesions arising in mice infected with c-Ha-ras indicated that the majority were benign cutaneous neoplasms (80%) and the remainder were subcutaneous malignant tumors (12) .
In contrast, light microscopic analysis of the ras/myc lesions revealed that the majority consisted of malignant neoplasms (18/35), while the rest were either benign neoplasms (12/35) or lesions consisting of foci of hemorrhage and/or acute and chronic inflammation, without evidence of malignancy (5/35). Because only a portion of each lesion was examined microscopically, it is possible that the latter 5 lesions represent areas of hemorrhage and inflammation adjacent to a tumor that was not represented in the available tissue section but was used for molecular analysis. The histologic classification ofthe ras/myc lesions is summarized in Table 2 and representative lesions are shown in Fig. 3 .
The malignant lesions were diverse in origin. A large number (7/18) occurred in the brain. Six of these tumors involved the cerebellum and had virtually identical histologic features (Fig. 3a) . These tumors exhibited a prominent angiocentric pattern, as well as a pattern in which tumor cells were arranged in lobulated groups of epithelial-like cells. These tumors behaved aggressively, invading the cerebellar parenchyma. Their histologic features are most consistent with a meningeal origin. The other brain tumor was a primitive malignant neoplasm that was highly cellular and composed ofhyperchromatic round cells with a scant amount of cytoplasm' and had metastasized to the liver.
Another large group of lesions (7/18) exhibited remarkably similar histologic features and consisted primarily of elongated spindle-shaped cells with elongated nuclei arranged in clusters and whorls (Fig. 3b) . In addition, nodular areas of epithelioid polygonal cells were present in four of these tumors and the other two had a prominent vascular component, reminiscent of angiosarcoma. Immunohistochemical analyses indicated that three of the lesions were epithelial in origin and ruled out a neuroectodermal, a smooth muscle, or skeletal muscle cell origin for the other lesions. The results of immunohistochemical studies suggested that the other spindle cell lesions are high grade sarcomas. The remainder of the malignant ras/myc tumors included three squamous cell carcinomas in the skin (Fig. 3c) and a poorly differentiated malignant neoplasm that replaced the renal medulla.
In summary, our results indicate that the ras and myc oncogenes, when jointly introduced into midgestation em- Proc. NatL Acad. Sci. USA 86 (1989) bryos induce a wide spectrum of neoplasms, the majority (90%) of which are malignant or premalignant. In contrast, exposure of embryos to myc or ras alone results in either inefficient tumor induction or induction of primarily benign lesions, respectively. Detection of Viral DNA and RNA. To correlate tumor formation with virus infection, DNAs were isolated from 12 lesions and the presence of the provirus was detected by Southern blotting analysis and probing with v-ras or v-myc radiolabeled probe (Fig. 1) . For v-ras, digestion of the DNA samples with BamHI generated an internal firagment carrying the v-ras sequences of 700 base pairs, indicating no gross rearrangement of the viral structure (Fig. 4A, lanes 2-10) . Endogenous mouse ras sequences were also detected (the two larger fragments present also in the negative control; lane 1) and served as an internal control for digestion and transfer of the DNA. The presence of the v-myc sequences was determined by Southern blotting analysis of the DNA samples after digestion with Bgl II, which generates a 3.0-kilobase (kb) internal v-myc fragment (Fig. 4P, lanes 2-10) . The endogenous mouse myc genes were not detected under the hybridization conditions used with a chicken v-myc radiolabeled probe (lane 1). To determine whether the tumors A __i-P...U.. contained one or multiple proviral structures the Southern blot ofDNAs that had been digested with Bgl II (from Fig. 4B) was denatured and reprobed with the v-Ha-ras oncogene to detect the flanking sequences (Fig. 4C) . This analysis indicated the presence of only a single provirus in each of the tumors induced by infection of midgestation embryos, suggesting that a single viral particle promoted each hyperplasia.
When RNA was isolated from 11 tumors and tested for viral transcripts by dot blot analysis, 8 of the 'samples were positive for viral RNA. Our inability to detect viral RNA in all samples is likely due to many of the tumors being necrotic or composed of tumor and normal tissue, which would result in RNA degradation or a lower sensitivity of detecting viral RNA. Fig. 5 shows that the expected full-length viral transcripts of 6 kb, as well as the spliced subgenomic RNA, were seen on Northern blots of 4 RNA samples extracted from ras/myc virus-induced tumors. These results support the conclusion that the embryonic cells carried intact proviruses that transcribed functional viral mRNA.
DISCUSSION
The aim of this study was to assess the transforming potential of the ras and myc oncogenes in the developing embryo. For this, replication-defective retroviral vectors that transduced either the ras, the myc, or both oncogenes were microinjected into midgestation mouse embryos. Because previous studies had shown that retroviruses are expressed in cells of most or all tissues of the midgestation embryo (8, 9), we expected that the virus would be expressed in every infected cell and that the spectrum of tumors arising in animals derived from injected embryos would reflect the oncogenic spectrum of the oncogenes.
The neoplasms induced by the myc virus alone were rare and resulted in a low incidence of diverse tumors that developed after a latency period of 15-22 weeks. When midgestation embryos were exposed to a vector transducing the human c-HRAS oncogene, tumor formation was more efficient and predominantly benign skin neoplasms appeared in 24% of the animals with a median latency of 4 weeks (12) . In contrast to the results obtained with the single oncogene carrying viruses, the ras/myc double oncogene virus had a dramatic effect on the fetuses. When concentrated virus with a titer comparable to that used for the single oncogene viruses was injected, only 1% of the injected fetuses survived to birth. Only when the virus stock was diluted prior to injection were live animals obtained, 27% of which developed rapidly growing tumors in a variety of tissues. Animals infected with the ras and myc oncogenes frequently developed lesions in the nervous system involving the brainstem, cerebellum, and cerebrum, whereas no brain lesions were promoted upon infection with the ras or myc oncogene alone. The cell types transformed by infection with both ras and myc oncogenes were diverse and included cells of neural, connective, and epithelial tissues but not of the hemopoietic system. It is possible that these are the fastest growing tumors, which kill the animal before slower tumors of other tissues become evident. Our results indicate that many cells of the developing embryo are highly susceptible to the combined expression of both oncogenes and are consistent with the hypothesis that the ras and myc oncogenes act synergistically in vivo in cellular transformation. It should be noted that the ras oncogene in the two ras-transducing vectors had a different origin. While the ras/myc double oncogene virus carried the v-Ha-ras gene, the DOEJ vector transduced the human c-HRAS gene (12) . We therefore do not have direct evidence that the v-Ha-ras oncogene causes a similar phenotype as the human c-HRAS gene when injected into midgestation embryos. However, because both oncogenes have been shown to have identical biological effects when infecting tissue culture cells or when injected into newborn mice (17) , our data strongly suggest that the combination of the ras and myc oncogenes not only significantly enhances the overall efficiency of tumor induction but also dramatically expands the range of cells that are vulnerable to transformation.
The oncogenes transduced by the vectors were transcriptionally controlled from the viral long terminal repeat, which has been shown to be efficiently expressed in cells of most or all tissues of the midgestation embryo (8, 9, 18) . The spectrum of tumors, therefore, does not reflect tissuerestricted expression of the oncogenes but rather their intrinsic oncogenic potential. The oncogenic potential of an oncogene may be affected by characteristics that are particular for certain tissues. Thus, while the combination of ras and myc induced tumors in many tissues, transformation induced by the ras oncogene alone was predominantly restricted to the skin. This is consistent with the hypothesis that tissue-specific factors such as expression of the cellular myc gene, which is elevated in skin (19) , cooperate with the ras oncogene in tumor promotion. Cooperation of both oncogenes has also been seen in prostate organ culture (11) . When the ras or myc oncogene was introduced singly, only premalignant lesions were induced. In contrast, infection of these cultures with the ras/myc virus resulted in aggressively growing and malignant tumors of various types.
The ras and myc oncogenes have been expressed in transgenic mice from a variety of different tissue-specific promoters (7, (20) (21) (22) (23) (24) (25) . While joint expression of both oncogenes resulted in accelerated tumor formation, single tumors appeared after a variable latency period, suggesting that although the ras and myc oncogenes cooperate in tumor formation, coexpression of both oncogenes was not sufficient, but that additional events were necessary for malignant progression (7) . Similarly, the latency between infection of embryos with the ras/myc virus and the development of lesions is consistent with the premise that other alterations are necessary for malignancy to occur.
Since normal cells can, in fact, repress the transformed phenotype of cells expressing oncogenes (26, 27) , part of the progression to malignancy is believed to be the capacity of a mutant cell to grow in the presence of normal tissue. Because in transgenic animals the promoter controlling the oncogenes is activated in many or all cells of a given tissue, the neoplastic proliferation may not be due to clonal expansion of a single transformed cell, but rather to abnormal growth of a group of cells. Because of the lack of suitable markers, the clonality of the tumors could not be assessed in studies with transgenic animals. In contrast, after injection of virus into midgestation embryos, only single cells become infected and a tumor must be the consequence of clonal outgrowth of a transformed cell. In our studies, Southern blots using the provirus as a convenient molecular marker indicated that all ras/myc-induced tumors were of monoclonal origin.
Human carcinomas have been shown to be of clonal origin (28) (29) (30) . The infection of midgestation embryos with oncogenic viruses may mimic the pathogenesis of naturally occurring tumors where a cell with a spontaneous mutation expands clonally to form a tumor in the presence of normal tissue. The exposure of mouse embryos to different oncogenes or combinations of oncogenes may, therefore, provide a useful and rapid means to assess their oncogenic potential within the developing organism.
